Serina Therapeutics (SER) Assets Average (2019 - 2026)

Serina Therapeutics has disclosed Assets Average across 8 years of filings, most recently posting $16.4 million for Q2 2026.

• In Q2 2026, Assets Average rose 109.07% year-over-year to $16.4 million; the TTM figure through Jun 2026 stood at $16.4 million (up 109.07% YoY), while the FY2025 annual figure was $6.8 million, down 12.85% from the prior year.
• Assets Average came in at $16.4 million for Q2 2026 at Serina Therapeutics, up from $9.7 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $16.4 million in Q2 2026 to a low of $497000.0 in Q2 2023.
• Average Assets Average over 5 years is $6.9 million, with a median of $7.1 million recorded in 2024.
• Year-over-year, Assets Average tumbled 81.23% in 2023 and jumped 2069.42% in 2024.
• Over 5 years, Assets Average stood at $2.6 million in 2022, then jumped by 303.47% to $10.6 million in 2023, then slumped by 33.14% to $7.1 million in 2024, then jumped by 36.76% to $9.7 million in 2025, then jumped by 69.21% to $16.4 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $16.4 million in Q2 2026, $9.7 million in Q4 2025, and $10.7 million in Q3 2025.